Terms: = Colorectal cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Treatment
48 results:
1. Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy in Appendiceal and colorectal cancer: Outcomes and Survival.
Djadou TM; Poh KS; Yellinek S; Fayazzadeh H; El-Hayek K; Simpfendorfer CH; DaSilva G; Wexner SD
Am Surg; 2023 Dec; 89(12):5757-5767. PubMed ID: 37155318
[TBL] [Abstract] [Full Text] [Related]
2. China special issue on gastrointestinal tumors-Regulatory-immunoscore-A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer.
Fang L; Yao Y; Guan X; Liao Y; Wang B; Cui L; Han S; Zou H; Su D; Ma Y; Liu B; Wang Y; Huang R; Ruan Y; Yu X; Yao Y; Liu C; Zhang Y
Int J Cancer; 2023 Dec; 153(11):1904-1915. PubMed ID: 37085990
[TBL] [Abstract] [Full Text] [Related]
3. [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric cancer].
Danishevich AM; Pospehova NI; Stroganova AM; Golovina DA; Nikulin MP; Kalinin AE; Nikolaev SE; Stilidi IS; Lyubchenko LN
Mol Biol (Mosk); 2023; 57(1):71-84. PubMed ID: 36976740
[TBL] [Abstract] [Full Text] [Related]
4. Pathologic stage of ypT0N+ rectal cancers following neo-adjuvant treatment: clinical interpretation of an orphan status.
Lorenzon L; De Luca R; Santoro G; Parini D; Rega D; Mellano A; Vigorita V; Jiménez-Rosellón R; Sandin M; Andriola V; Gallo G; Marino G; Turati L; Marsanic P; Marano L; Lucarini A; Aprile A; Sagnotta A; Biondi A;
Pathol Res Pract; 2022 Sep; 237():154002. PubMed ID: 35849868
[TBL] [Abstract] [Full Text] [Related]
5. Differential Outcomes in Codon 12/13 and Codon 61
Cleary JM; Wang V; Heist RS; Kopetz ES; Mitchell EP; Zwiebel JA; Kapner KS; Chen HX; Li S; Gray RJ; McShane LM; Rubinstein LV; Patton DR; Meric-Bernstam F; Dillmon MS; Williams PM; Hamilton SR; Conley BA; Aguirre AJ; O'Dwyer PJ; Harris LN; Arteaga CL; Chen AP; Flaherty KT
Clin Cancer Res; 2021 Jun; 27(11):2996-3004. PubMed ID: 33637626
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNAs differential expression profile in metastatic colorectal cancer: A pilot study with literature review.
Francone E; Gentilli S; Santori G; Stabilini C; Fornaro R; Frascio M
Surg Oncol; 2021 Jun; 37():101524. PubMed ID: 33556883
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
Grant RC; Denroche R; Jang GH; Nowak KM; Zhang A; Borgida A; Holter S; Topham JT; Wilson J; Dodd A; Jang R; Prince R; Karasinska JM; Schaeffer DF; Wang Y; Zogopoulos G; Berry S; Simeone D; Renouf DJ; Notta F; O'Kane G; Knox J; Fischer S; Gallinger S
Gut; 2021 Oct; 70(10):1894-1903. PubMed ID: 32933947
[TBL] [Abstract] [Full Text] [Related]
8. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract] [Full Text] [Related]
9. Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental treatments.
Coquerelle S; Darlington M; Michel M; Durand M; Borget I; Baffert S; Marino P; Perrier L; Durand-Zaleski I;
Value Health; 2020 Jul; 23(7):898-906. PubMed ID: 32762992
[TBL] [Abstract] [Full Text] [Related]
10. Asymmetric mutant-enriched polymerase chain reaction and quantitative DNA melting analysis of KRAS mutation in colorectal cancer.
Botezatu IV; Kondratova VN; Shelepov VP; Mazurenko NN; Tsyganova IV; Susova OY; Lichtenstein AV
Anal Biochem; 2020 Feb; 590():113517. PubMed ID: 31782995
[TBL] [Abstract] [Full Text] [Related]
11. Global variation in the long-term outcomes of ypT0 rectal cancers.
Lorenzon L; Evrard S; Beets G; Gonzalez-Moreno S; Kovacs T; D'Ugo D; Polom K;
Eur J Surg Oncol; 2020 Mar; 46(3):420-428. PubMed ID: 31733929
[TBL] [Abstract] [Full Text] [Related]
12. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
[TBL] [Abstract] [Full Text] [Related]
13. Blood-Based Prediction of Tumor Relapse: The cfDNA Forecast.
Siravegna G; Corcoran RB
Cancer Discov; 2018 Oct; 8(10):1213-1215. PubMed ID: 30279194
[No Abstract] [Full Text] [Related]
14. Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to treatment Failure in the PROSPECT-C Phase II colorectal cancer Clinical Trial.
Khan KH; Cunningham D; Werner B; Vlachogiannis G; Spiteri I; Heide T; Mateos JF; Vatsiou A; Lampis A; Damavandi MD; Lote H; Huntingford IS; Hedayat S; Chau I; Tunariu N; Mentrasti G; Trevisani F; Rao S; Anandappa G; Watkins D; Starling N; Thomas J; Peckitt C; Khan N; Rugge M; Begum R; Hezelova B; Bryant A; Jones T; Proszek P; Fassan M; Hahne JC; Hubank M; Braconi C; Sottoriva A; Valeri N
Cancer Discov; 2018 Oct; 8(10):1270-1285. PubMed ID: 30166348
[TBL] [Abstract] [Full Text] [Related]
15. Spindle Assembly Disruption and cancer Cell Apoptosis with a cltc-Binding Compound.
Bond MJ; Bleiler M; Harrison LE; Scocchera EW; Nakanishi M; G-Dayanan N; Keshipeddy S; Rosenberg DW; Wright DL; Giardina C
Mol Cancer Res; 2018 Sep; 16(9):1361-1372. PubMed ID: 29769406
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of factors influencing molecular testing at diagnostic of colorectal cancer.
Thiebault Q; Defossez G; Karayan-Tapon L; Ingrand P; Silvain C; Tougeron D
BMC Cancer; 2017 Nov; 17(1):765. PubMed ID: 29137623
[TBL] [Abstract] [Full Text] [Related]
17. Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancer.
Shimada Y; Yagi R; Kameyama H; Nagahashi M; Ichikawa H; Tajima Y; Okamura T; Nakano M; Nakano M; Sato Y; Matsuzawa T; Sakata J; Kobayashi T; Nogami H; Maruyama S; Takii Y; Kawasaki T; Homma KI; Izutsu H; Kodama K; Ring JE; Protopopov A; Lyle S; Okuda S; Akazawa K; Wakai T
Hum Pathol; 2017 Aug; 66():1-9. PubMed ID: 28235632
[TBL] [Abstract] [Full Text] [Related]
18. Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.
Zekri J; Al-Shehri A; Mahrous M; Al-Rehaily S; Darwish T; Bassi S; El Taani H; Al Zahrani A; Elsamany S; Al-Maghrabi J; Sadiq BB
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218784
[TBL] [Abstract] [Full Text] [Related]
19. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing.
Mack E; Stabla K; Riera-Knorrenschild J; Moll R; Neubauer A; Brendel C
BMC Cancer; 2016 Aug; 16():585. PubMed ID: 27485514
[TBL] [Abstract] [Full Text] [Related]
20. Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery.
Denis JA; Patroni A; Guillerm E; Pépin D; Benali-Furet N; Wechsler J; Manceau G; Bernard M; Coulet F; Larsen AK; Karoui M; Lacorte JM
Mol Oncol; 2016 Oct; 10(8):1221-31. PubMed ID: 27311775
[TBL] [Abstract] [Full Text] [Related]
[Next]
